Purchase Order W81K0219P0006
Award Date 10/11/18
Potential Completion Date 12/31/18
Potential Value $96K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Joint Base Lewis-McChord, WA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract was awarded to Prolacta Bioscience, Inc. by the Department of the Army Medical Command. The contract, valued at $150,000.00, is for the provision of human milk-based neonatal nutrition products to support premature and critically ill infants treated at military medical facilities. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type, and a performance period ending on September 30, 2022. Prolacta Bioscience, a manufacturer of goods, has...
- Prolacta Bioscience, Inc., a for-profit manufacturer, was awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call by the Defense Health Agency (DHA) to provide infant breast milk products in support of neonatal intensive care unit patients at military medical facilities. The potential value of this BPA call is $24,943.82, with a completion date of September 30, 2024. Prolacta Bioscience has held multiple previous contracts with the DHA and Department of the Army Medical Command to...
- The Defense Health Agency awarded a $35,818.34 firm fixed price call under an existing Blanket Purchase Agreement to Prolacta Bioscience, Inc. for the purchase of human milk-based nutritional products to support premature infants in the Neonatal Intensive Care Unit at Tripler Army Medical Center. The contract, which commenced on October 1, 2025, and extends through September 30, 2026, requires no set-aside designation. Prolacta Bioscience, headquartered in City of Industry, California,...
- This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc., a for-profit manufacturer of human milk-based nutritional products. The $24,037.95 contract is for the delivery of breastmilk products to support premature and critically ill infants in military medical facilities. Prolacta Bioscience has also been awarded three significant indefinite delivery vehicle (IDV) contracts by the DHA, valued at $1.75...
- This firm fixed price contract was awarded by the Defense Health Agency to Prolacta Bioscience, Inc. to provide Prolacta's proprietary human milk-based nutritional products for use with infants in the neonatal intensive care unit (NICU) at Tripler Army Medical Center. The $15,536.12 contract is a call against a larger $250,000 single-award blanket purchase agreement for donor human milk and a $1.75 million single-award BPA for various human milk-based products to support military treatment...
- This federal contract award to Prolacta Bioscience, Inc. is for the delivery of pre-natal formula and food supplements to the Defense Health Agency (DHA), a component of the U.S. Department of Defense. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price, valued at $114,925.60. The period of performance extends through September 27, 2024. This contract is not associated with any set-aside programs. Prolacta Bioscience, a for-profit manufacturer of human milk-based...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc. for the purchase of human milk-based breastmilk fortifiers for premature infants in the Neonatal Intensive Care Unit (NICU) at Tripler Army Medical Center. The contract has a ceiling value of $24,838.83 and a period of performance through September 30, 2025. Prolacta Bioscience is a for-profit manufacturer of human milk-based nutritional products for...
- Prolacta Bioscience, Inc., a for-profit manufacturer of goods, has been awarded a Blanket Purchase Agreement (BPA) Call contract from the Defense Health Agency (DHA) to provide breastmilk supplementation products for neonatal intensive care unit (NICU) patients. The $13,022.86 firm fixed price contract has a performance period through September 30, 2024. Prolacta Bioscience, which holds two active indefinite delivery vehicles with the DHA valued at up to $250,000 and $1.75 million, delivers a...
- This firm fixed price contract was awarded by the Defense Health Agency to Prolacta Bioscience, Inc. to provide breastmilk products for premature infants in the Neonatal Intensive Care Unit at Tripler Army Medical Center. The contract has a potential value of $13,444.03 and a completion date of September 30, 2023. No set-aside designation was used for this contract award. Prolacta Bioscience will deliver their breastmilk-based nutritional products to support premature infants in the NICU at...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Subsistence to Anham FZCO, a for-profit limited liability company located in the United Arab Emirates. The contract is for the delivery of milk to support U.S. forces stationed overseas, with a total ceiling value of $1,306.80. The delivery order was awarded on December 14, 2018 with a period of performance through December 26, 2018. This award is part of a larger Indefinite Delivery Contract...